Effects of oseltamivir treatment of index patients with influenza on secondary household illness in an urban setting in Bangladesh: secondary analysis of a randomised, placebo-controlled trial
- 1 June 2015
- journal article
- research article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 15 (6) , 654-662
Abstract
No abstract availableKeywords
Funding Information
- CDC (grant number 1U01P000127)
This publication has 16 references indexed in Scilit:
- Effects of Oseltamivir Treatment on Duration of Clinical Illness and Viral Shedding and Household Transmission of Influenza VirusClinical Infectious Diseases, 2010
- Antiviral Effects on Influenza Viral Transmission and Pathogenicity: Observations from Household-based TrialsAmerican Journal of Epidemiology, 2006
- Strategies for mitigating an influenza pandemicNature, 2006
- Effectiveness of Oseltamivir in Preventing Influenza in Household ContactsA Randomized Controlled TrialJAMA, 2001
- Oral oseltamivir treatment of influenza in childrenThe Pediatric Infectious Disease Journal, 2001
- Inhaled Zanamivir for the Prevention of Influenza in FamiliesNew England Journal of Medicine, 2000
- Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trialThe Lancet, 2000
- Use of the Selective Oral Neuraminidase Inhibitor Oseltamivir to Prevent InfluenzaNew England Journal of Medicine, 1999
- Zanamivir in the Prevention of Influenza Among Healthy AdultsJAMA, 1999
- Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus InfectionsNew England Journal of Medicine, 1997